Skip to main content

IL-17

      RT @MeralElRamahiMD: #EULAR2021 bDMARD and TNF-i naive patients w/ r-axSpA without evidence of objective inflammation (n
      #EULAR2021 bDMARD and TNF-i naive patients w/ r-axSpA without evidence of objective inflammation (normal CRP & MRI ) showed ASA40 response w/ ixekizumab @RheumNow https://t.co/5KT8A81auq
      ×